Familial parathyroid tumours—comparison of clinical profiles between syndromes

[1]  W. Simonds,et al.  Familial Hyperparathyroidism , 2021, Frontiers in Endocrinology.

[2]  P. Chanson,et al.  Clinical aspects of multiple endocrine neoplasia type 1 , 2021, Nature Reviews Endocrinology.

[3]  T. Else,et al.  Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia , 2020, Hormones and Cancer.

[4]  S. Wilcox,et al.  Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort , 2020, Clinical endocrinology.

[5]  G. Pennelli,et al.  Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations , 2020, World Journal of Surgery.

[6]  M. Iacobone,et al.  Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature , 2019, International journal of endocrinology.

[7]  Falchetti Alberto,et al.  Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism. , 2018, Best practice & research. Clinical endocrinology & metabolism.

[8]  G. Valk,et al.  The Importance of an Early and Accurate MEN1 Diagnosis , 2018, Front. Endocrinol..

[9]  A. Al-Salameh,et al.  Update on multiple endocrine neoplasia Type 1 and 2. , 2018, Presse medicale.

[10]  W. Simonds,et al.  Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. , 2018, Journal of the American College of Surgeons.

[11]  S. Marx,et al.  Familial Hyperparathyroidism – Disorders of Growth and Secretion in Hormone-Secretory Tissue , 2017, Hormone and Metabolic Research.

[12]  R. Thakker.  Genetics of parathyroid tumours , 2016, Journal of internal medicine.

[13]  B. Carnaille,et al.  Hereditary hyperparathyroidism—a consensus report of the European Society of Endocrine Surgeons (ESES) , 2015, Langenbeck's Archives of Surgery.

[14]  M. Santoro,et al.  Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[16]  B. Harding,et al.  Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. , 2004, The Journal of clinical endocrinology and metabolism.

[17]  R. Thakker,et al.  Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions , 2002, Clinical endocrinology.

[18]  A. Howie,et al.  Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .